Performant Financial (PFMT) Stock Forecast, Price & News

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Performant Financial in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" PFMT shares.
View PFMT analyst ratings or view top-rated stocks.

1 Wall Street research analysts have issued 12 month target prices for Performant Financial's shares. Their PFMT share price forecasts range from $8.00 to $8.00. On average, they predict the company's share price to reach $8.00 in the next twelve months. This suggests a possible upside of 185.7% from the stock's current price.
View analysts price targets for PFMT or view top-rated stocks among Wall Street analysts.

Performant Financial's stock was trading at $3.61 on January 1st, 2023. Since then, PFMT shares have decreased by 22.4% and is now trading at $2.80.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Monday, August 14th 2023.
View our PFMT earnings forecast.

Performant Financial Co. (NASDAQ:PFMT) posted its earnings results on Tuesday, November, 9th. The business services provider reported ($0.03) EPS for the quarter, topping analysts' consensus estimates of ($0.08) by $0.05. The business services provider earned $28.58 million during the quarter. Performant Financial had a negative trailing twelve-month return on equity of 10.89% and a negative net margin of 8.35%. During the same quarter in the prior year, the business earned $0.05 earnings per share.

51 employees have rated Performant Financial Chief Executive Officer Lisa Im on Glassdoor.com. Lisa Im has an approval rating of 53% among the company's employees. This puts Lisa Im in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Performant Financial investors own include OPKO Health (OPK), Actinium Pharmaceuticals (ATNM), BIOLASE (BIOL), AcelRx Pharmaceuticals (ACRX), Bank of America (BAC), Catalyst Biosciences (CBIO), Clean Energy Fuels (CLNE), Imunon (CLSN), Comstock Resources (CRK) and Edap Tms (EDAP).

Performant Financial trades on the NASDAQ under the ticker symbol "PFMT."

Performant Financial's stock is owned by a variety of institutional and retail investors. Top institutional investors include Prescott Group Capital Management L.L.C. (20.88%), First Light Asset Management LLC (10.87%), Cooper Creek Partners Management LLC (4.84%), Punch & Associates Investment Management Inc. (3.39%), Mirador Capital Partners LP (2.14%) and Renaissance Technologies LLC (1.13%). Insiders that own company stock include Ecmc Group, Inc, Eric Yanagi, Parthenon Dcs Holdings, Llc, Pcp Managers Gp, Llc and Prescott Group Capital Managem.
View institutional ownership trends.

Shares of PFMT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PFMT stock can currently be purchased for approximately $2.80.

Performant Financial (NASDAQ:PFMT) has a market capitalization of $211.41 million and generates $107.83 million in revenue each year. The business services provider earns $-6,540,000.00 in net income (profit) each year or ($0.12) on an earnings per share basis.

The company employs 1,023 workers across the globe.

Performant Financial's mailing address is 333 North Cayons Parkway, Livermore CA, 94551. The official website for the company is performantcorp.com. The business services provider can be reached via phone at (925) 960-4800, via email at investors@performantcorp.com, or via fax at 925-960-4880.